ReviewRenal failure2025
The exocyst in ciliogenesis.
Review in Renal failure, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The primary cilium is an organelle found on different cell types in many organs, and is important for human health including the kidney. Diseases due to abnormal or absent cilia are termed ciliopathies and ADPKD is one of the most common ciliopathies and the fourth leading cause of ESKD. The mechanisms of how primary cilia work remain incompletely understood. One particular axis of ciliary function that is especially unclear is the role of the highly-conserved eight-subunit exocyst trafficking complex, which is critically involved in transporting proteins from the trans-Golgi network to the cilium. The goal of this review article is to cover key aspects of exocyst function, how these are known to or are predicted to impinge on ciliary function, and to point out areas that need further research. The exocyst has been shown to be regulated by many different small GTPases of the Rho, Ral, Rab, and Arf families which likely give the exocyst specificity of function. The exocyst has been implicated in several intracellular signaling pathways involving the cilium including the MAPK and phosphoinositide pathways. The exocyst and its regulators have also been found in urinary extracellular vesicles suggesting that the exocyst may be involved in 'urocrine' signaling and repair following AKI. There is an urgent need to develop new strategies to address exocyst function in the context of cilia, which will greatly benefit our understanding of cilia as well as how disrupted exocyst function in cilia leads to disease, which, in turn, should lead to novel therapeutics.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.